Bioactive compounds and metabolites from grapes and red wine in breast cancer chemoprevention and therapy

37Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

Phytochemicals and their metabolites are not considered essential nutrients in humans, although an increasing number of well-conducted studies are linking their higher intake with a lower incidence of non-communicable diseases, including cancer. This review summarizes the current findings concerning the molecular mechanisms of bioactive compounds from grapes and red wine and their metabolites on breast cancer—the most commonly occurring cancer in women—chemoprevention and treatment. Flavonoid compounds like flavonols, monomeric catechins, proanthocyanidins, anthocyanins, anthocyanidins and non-flavonoid phenolic compounds, such as resveratrol, as well as their metabolites, are discussed with respect to structure and metabolism/bioavailability. In addition, a broad discussion regarding in vitro, in vivo and clinical trials about the chemoprevention and therapy using these molecules is presented.

Cite

CITATION STYLE

APA

Ferraz da Costa, D. C., Rangel, L. P., Quarti, J., Santos, R. A., Silva, J. L., & Fialho, E. (2020, August 1). Bioactive compounds and metabolites from grapes and red wine in breast cancer chemoprevention and therapy. Molecules. MDPI AG. https://doi.org/10.3390/molecules25153531

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free